Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1988 Jun;51(6):820–825. doi: 10.1136/jnnp.51.6.820

Occurrence and isotype of antibodies against peripheral nerve myelin in serum from patients with peripheral neuropathy and healthy controls.

M Cruz 1, J Ernerudh 1, T Olsson 1, B Höjeberg 1, H Link 1
PMCID: PMC1033154  PMID: 3404188

Abstract

Antibodies against peripheral nerve myelin have previously been demonstrated in serum from patients with peripheral neuropathy and IgM paraproteinaemia, and a causal relationship has been suggested. Using enzyme-linked immunosorbent assay (ELISA), anti-myelin antibodies were found in sera from eight of 16 patients with polyneuropathy and paraproteinaemia, but also in 17% of 109 patients with peripheral neuropathy lacking monoclonal immunoglobulin, including five of 10 patients with Charcot-Marie-Tooth disease, and in 16% of 142 blood donors. The antibodies were mostly of IgM class in the two neuropathy groups, while blood donors had mostly IgA antibodies, and a few subjects of each group had antimyelin antibodies of two different isotypes. Western blot confirmed the ELISA results in a majority of antibody positive sera and revealed a 25-30 kD myelin target antigen for sera from the three groups, and for some of the non-paraproteinaemic sera also a 100 kD myelin target antigen. Our results demonstrate that the presence of serum autoantibodies against peripheral nerve myelin does not necessarily indicate a pathological event.

Full text

PDF
820

Images in this article

822Image
on p.822

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Braun P. E., Frail D. E., Latov N. Myelin-associated glycoprotein is the antigen for a monoclonal IgM in polyneuropathy. J Neurochem. 1982 Nov;39(5):1261–1265. doi: 10.1111/j.1471-4159.1982.tb12563.x. [DOI] [PubMed] [Google Scholar]
  2. Chou K. H., Ilyas A. A., Evans J. E., Quarles R. H., Jungalwala F. B. Structure of a glycolipid reacting with monoclonal IgM in neuropathy and with HNK-1. Biochem Biophys Res Commun. 1985 Apr 16;128(1):383–388. doi: 10.1016/0006-291x(85)91690-0. [DOI] [PubMed] [Google Scholar]
  3. Cook S. D., Dowling P. C. the role of autoantibody and immune complexes in the pathogenesis of Guillain-Barré syndrome. Ann Neurol. 1981;9 (Suppl):70–79. doi: 10.1002/ana.410090712. [DOI] [PubMed] [Google Scholar]
  4. Cruz M., Olsson T., Ernerudh J., Höjeberg B., Link H. Immunoblot detection of oligoclonal anti-myelin basic protein IgG antibodies in cerebrospinal fluid in multiple sclerosis. Neurology. 1987 Sep;37(9):1515–1519. doi: 10.1212/wnl.37.9.1515. [DOI] [PubMed] [Google Scholar]
  5. Ernerudh J., Brodtkorb E., Olsson T., Vedeler C. A., Nyland H., Berlin G. Peripheral neuropathy and monoclonal IgM with antibody activity against peripheral nerve myelin; effect of plasma exchange. J Neuroimmunol. 1986 May;11(3):171–178. doi: 10.1016/0165-5728(86)90001-9. [DOI] [PubMed] [Google Scholar]
  6. Geczy C., Raper R., Roberts I. M., Meyer P., Bernard C. C. Macrophage procoagulant activity as a measure of cell-mediated immunity to P2 protein of peripheral nerves in the Guillain-Barré syndrome. J Neuroimmunol. 1985 Aug;9(3-4):179–191. doi: 10.1016/s0165-5728(85)80017-5. [DOI] [PubMed] [Google Scholar]
  7. Guilbert B., Dighiero G., Avrameas S. Naturally occurring antibodies against nine common antigens in human sera. I. Detection, isolation and characterization. J Immunol. 1982 Jun;128(6):2779–2787. [PubMed] [Google Scholar]
  8. Julien J., Vital C., Vallat J. M., Lagueny A., Ferrer X., Leboutet M. J. Chronic demyelinating neuropathy with IgM-producing lymphocytes in peripheral nerve and delayed appearance of "benign" monoclonal gammopathy. Neurology. 1984 Oct;34(10):1387–1389. doi: 10.1212/wnl.34.10.1387. [DOI] [PubMed] [Google Scholar]
  9. Kadlubowski M., Hughes R. A., Gregson N. A. Experimental allergic neuritis in the Lewis rat: characterization of the activity of peripheral myelin and its major basic protein,P2. Brain Res. 1980 Feb 24;184(2):439–454. doi: 10.1016/0006-8993(80)90811-2. [DOI] [PubMed] [Google Scholar]
  10. Kahn S. N., Riches P. G., Kohn J. Paraproteinaemia in neurological disease: incidence, associations, and classification of monoclonal immunoglobulins. J Clin Pathol. 1980 Jul;33(7):617–621. doi: 10.1136/jcp.33.7.617. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  12. MELNICK S. C. Thirty-eight cases of the Guillain-Barre syndrome: an immunological study. Br Med J. 1963 Feb 9;1(5327):368–373. doi: 10.1136/bmj.1.5327.368. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Melmed C., Frail D., Duncan I., Braun P., Danoff D., Finlayson M., Stewart J. Peripheral neuropathy with IgM kappa monoclonal immunoglobulin directed against myelin-associated glycoprotein. Neurology. 1983 Nov;33(11):1397–1405. doi: 10.1212/wnl.33.11.1397. [DOI] [PubMed] [Google Scholar]
  14. Nobile-Orazio E., Hays A. P., Latov N., Perman G., Golier J., Shy M. E., Freddo L. Specificity of mouse and human monoclonal antibodies to myelin-associated glycoprotein. Neurology. 1984 Oct;34(10):1336–1342. doi: 10.1212/wnl.34.10.1336. [DOI] [PubMed] [Google Scholar]
  15. Nobile-Orazio E., Latov N., Hays A. P., Takatsu M., Abrams G. M., Sherman W. H., Miller J. R., Messito M. J., Saito T., Tahmoush A. Neuropathy and anti-MAG antibodies without detectable serum M-protein. Neurology. 1984 Feb;34(2):218–221. doi: 10.1212/wnl.34.2.218. [DOI] [PubMed] [Google Scholar]
  16. Nutt J. G. Effect of cholinergic agents in Huntington's disease: a reappraisal. Neurology. 1983 Jul;33(7):932–935. doi: 10.1212/wnl.33.7.932. [DOI] [PubMed] [Google Scholar]
  17. O'Shannessy D. J., Ilyas A. A., Dalakas M. C., Mendell J. R., Quarles R. H. Specificity of human IgM monoclonal antibodies from patients with peripheral neuropathy. J Neuroimmunol. 1986 Apr;11(2):131–136. doi: 10.1016/0165-5728(86)90114-1. [DOI] [PubMed] [Google Scholar]
  18. O'Shannessy D. J., Willison H. J., Inuzuka T., Dobersen M. J., Quarles R. H. The species distribution of nervous system antigens that react with anti-myelin-associated glycoprotein antibodies. J Neuroimmunol. 1985 Sep;9(5):255–268. doi: 10.1016/s0165-5728(85)80024-2. [DOI] [PubMed] [Google Scholar]
  19. Olsson T., Kostulas V., Link H. Improved detection of oligoclonal IgG in cerebrospinal fluid by isoelectric focusing in agarose, double-antibody peroxidase labeling, and avidin-biotin amplification. Clin Chem. 1984 Jul;30(7):1246–1249. [PubMed] [Google Scholar]
  20. Steck A. J., Murray N., Meier C., Page N., Perruisseau G. Demyelinating neuropathy and monoclonal IgM antibody to myelin-associated glycoprotein. Neurology. 1983 Jan;33(1):19–23. doi: 10.1212/wnl.33.1.19. [DOI] [PubMed] [Google Scholar]
  21. Stefansson K., Marton L. S., Dieperink M. E., Molnar G. K., Schlaepfer W. W., Helgason C. M. Circulating autoantibodies to the 200,000-dalton protein of neurofilaments in the serum of healthy individuals. Science. 1985 May 31;228(4703):1117–1119. doi: 10.1126/science.4039466. [DOI] [PubMed] [Google Scholar]
  22. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A. 1979 Sep;76(9):4350–4354. doi: 10.1073/pnas.76.9.4350. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES